The promoter methylation levels of selected candidate genes (RASSF1A, DAPK1, SOX1, HOXA9, HIC1, SPARC, and SFRP1) were quantitatively evaluated by MethyLight in tumor DNA samples of patients with EOC. This evidence concerns the gene SFRP1 and neoplasm.